Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:17 PM
Ignite Modification Date:
2025-12-24 @ 10:17 PM
NCT ID:
NCT01340235
Eligibility Criteria:
Inclusion Criteria:
* Severe Dowling Meara EBS patients (2 or more new blisters a day)
* signature of informed consent
* Patient of 2 sexes
* Age from 6 months to 8 years. From this age we consider that the patient will less need this treatment or can take cyclines.
* Systematic Obtaining of the consent lit(enlightened) by the relatives(parents) of the child, after information about the objectives and the constraints of the study.
* Agreement of the minor
* Patient member to the Social Security
Exclusion Criteria:
* Patient allergic to the erythromycin
* Patient presenting an intolerance to the fructose, a syndrome of malabsorption some glucose and some galactose or a deficit sucrase-isomaltase
* Renal and\\or hepatic Insufficiency
* Patient taking a medicine against indicated or misadvised in association with the erythromycin
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
6 Months
Maximum Age:
8 Years
Study:
NCT01340235
Study Brief:
Protocol Section:
NCT01340235